SOURCE: Radiant Insights, Inc.

Radiant Insights, Inc.

March 29, 2016 07:30 ET

Breast Cancer Therapeutics in Asia-Pacific Market to Reach $2.4 Billion by 2020: Radiant Insights, Inc.

SAN FRANCISCO, CA--(Marketwired - Mar 29, 2016) - Breast cancer -- a harmful neoplasm -- is the second-most common tumor type as well as the most common tumor in women worldwide.

The breast cancer therapeutics market in the Asia-Pacific (APAC) is projected to reach USD 2.4 bn. growing at a CAG rate of over 7.5% by 2020. In 2013, the estimated breast cancer therapeutics market in the Asia-Pacific countries such as Japan, India, china, and Australia was USD 1.5 bn. with Japan being the largest regional market. It accounted for over 58% of the total share.

Browse Full Research Report With TOC On "Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options" at: http://www.radiantinsights.com/research/breast-cancer-therapeutics-in-asia-pacific-markets-to-2020-novel-her-2-positive-therapies-provide-diversified-treatment-options

China accounted for over 21% and Australia accounted for over 16% of the total share. India accounted for the lowest market share of 5%, but it is projected to experience a rapid growth during the forecast period (2014-2020) with a CAGR of 13.8%, compared to Australia at 7.8% and China and Japan both at 7.7%.

The market for breast cancer therapeutics is expected to gain considerable growth during the forecast period mainly due to increasing occurrence of breast cancer, advanced novel therapies etc. The major reasons for increasing occurrences of breast cancer are unhealthy lifestyle habits, genetic profiles of the patients, and direct contact with dangerous radiations. In addition to this, increasing female elderly population base, as well as government programs spreading awareness amongst people, are high impact rendering factors of the global market for the breast cancer therapeutics.

Based on various treatments, the global market for breast cancer therapeutics is segmented into surgery & radiation therapy, chemotherapy, hormonal therapy, and targeted therapy.

Browse All Reports of This Category at: www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare

As of 2014, the chemotherapy sector dominated the global market mainly due to the factors such as preventing the disease from spreading, shrinking of existing tumors, destroying cancer cells, and so on. The chemotherapy sector is further sub-segmented into antimetabolites, anthracyclines, taxanes, alkylating agents, and epothilones. The targeted therapy sector is expected to be the topmost sector because of the major benefits offered by it like lesser collateral damages to the surrounding tissues, localized action, increased efficacy, faster recovery, less toxic levels etc. The targeted therapy sector is sub-segmented into tyrosine kinase inhibitors and monoclonal antibodies.

Some of the major players in the market are Bipar Sciences, Novartis AG, Pfizer, Oncogenex, Astellas, BioNumerik Pharmaceuticals, and Apthera Inc.

Scope

The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in the breast cancer therapeutics in the four APAC markets of Australia, China, India and Japan.The report includes --

  • Disease overview, as well as treatment algorithms and treatment usage patterns
  • Market size and forecast for the APAC breast cancer market from 2013 to 2020
  • Major marketed products in the APAC region along with a heat map of product performance
  • In-depth pipeline analysis for global pipeline in breast cancer drugs along with clinical trial failure rate analysis

Reasons to buy

The report will enhance your decision-making capability by allowing you to --

  • Align your product portfolio to the markets with high growth potential
  • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
  • Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the breast cancer drugs market

Explore Other Reports On "Pharmaceuticals And Healthcare" Category At-

  • Biopharmaceuticals Companies -

http://www.radiantinsights.com/research/biopharmaceuticals-companies-in-china

  • Anesthetic Drugs Companies -

http://www.radiantinsights.com/research/anesthetic-drugs-companies-in-china

About Radiant Insight
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.

Contact Information